The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
. Survival of persons with and without HIV infection in Denmark, 1995-2005.
Abstract
BACKGROUND: The expected survival of HIV-infected patients is of major public health interest. OBJECTIVE: To estimate survival time and age-specific mortality rates of an HIV-infected population compared with that of the general population. DESIGN: Population-based cohort study. SETTING: All HIV-infected persons receiving care in Denmark from 1995 to 2005. PATIENTS: Each member of the nationwide Danish HIV Cohort Study was matched with as many as 99 persons from the general population according to sex, date of birth, and municipality of residence. MEASUREMENTS: The authors computed Kaplan-Meier life tables with age as the time scale to estimate survival from age 25 years. Patients with HIV infection and corresponding persons from the general population were observed from the date of the patient's HIV diagnosis until death, emigration, or 1 May 2005. RESULTS: 3990 HIV-infected patients and 379,872 persons from the general population were included in the study, yielding 22,744 (median, 5.8 y/person) and 2,689,287 (median, 8.4 years/person) person-years of observation. Three percent of participants were lost to follow-up. From age 25 years, the median survival was 19.9 years (95% CI, 18.5 to 21.3) among patients with HIV infection and 51.1 years (CI, 50.9 to 51.5) among the general population. For HIV-infected patients, survival increased to 32.5 years (CI, 29.4 to 34.7) during the 2000 to 2005 period. In the subgroup that excluded persons with known hepatitis C coinfection (16%), median survival was 38.9 years (CI, 35.4 to 40.1) during this same period. The relative mortality rates for patients with HIV infection compared with those for the general population decreased with increasing age, whereas the excess mortality rate increased with increasing age. LIMITATIONS: The observed mortality rates are assumed to apply beyond the current maximum observation time of 10 years. CONCLUSIONS: The estimated median survival is more than 35 years for a young person diagnosed with HIV infection in the late highly active antiretroviral therapy era. However, an ongoing effort is still needed to further reduce mortality rates for these persons compared with the general population.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“There is an emerging consensus in the scientific community that HIV infection hastens the process of aging and that illnesses that appear typically in the elderly are highly frequent among HIV-infected individuals, even in those with therapy-induced suppression of the virus below detection limits [59,60].”
From T-cell aging in rheumatoid arthritis (2014) · cites this paper as [59]
In the citing paper
“When compared to behaviorally and demographically similar HIV-uninfected individuals, people with HIV infection, even those receiving effective ART with suppression of virus to levels below typical detection limits, experience excess morbidity and mortality (3,4).”
Citations
Cites
Decline in the AIDS and death rates in the EuroSIDA study: an observational study
Mocroft, A., Ledergerber, B., Katlama, C., Kirk, O., Reiss, P., Monforte, A. D., Knysz, B., Dietrich, M., Phillips, A. N., & Lundgren, J. D. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13802-0 · Cited by 1,241
When an Entire Country Is a Cohort
Frank, L. (2000) · Science · doi:10.1126/science.287.5462.2398 · Cited by 865
Galván, F. H., Bing, E. G., Fleishman, J. A., London, A. S., Caetano, R., Burnam, M. A., Longshore, D. L., Morton, S. C., Orlando, M., & Shapiro, M. F. (2002) · Journal of Studies on Alcohol · doi:10.15288/jsa.2002.63.179 · Cited by 438
Laing, S. P., Swerdlow, A. J., Slater, S. D., Botha, J. L., Burden, A. C., Waugh, N. R., Smith, A. W. M., Hill, R. D., Bingley, P. J., Patterson, C. C., et al. (1999) · Diabetic Medicine · doi:10.1046/j.1464-5491.1999.00075.x · Cited by 427
Savès, M., Chêne, G., Ducimetière, P., Leport, C., Moal, G. L., Amouyel, P., Arveiler, D., Ruidavets, J., Reynes, J., Bingham, A., et al. (2003) · Clinical Infectious Diseases · doi:10.1086/375844 · Cited by 399
Cigarette Smoking and the Desire to Quit Among Individuals Living with HIV
Mamary, E. M., Bahrs, D., & Martinez, S. A. (2002) · AIDS Patient Care and STDs · doi:10.1089/108729102753429389 · Cited by 155
UK CHIC Study Group The UK Collaborative Group on HIV Drug Resistance (2005) · AIDS · doi:10.1097/01.aids.0000162337.58557.3d · Cited by 149
Estimating the proportion of patients infected with HIV who will die of comorbid diseases
Braithwaite, R. S., Justice, A. C., Chang, C. H., Fusco, J. S., Raffanti, S. R., Wong, J. B., & Roberts, M. S. (2005) · The American Journal of Medicine · doi:10.1016/j.amjmed.2004.12.034 · Cited by 136
Lundgren, J. D., Mocroft, A., Gatell, J. M., Ledergerber, B., Monforte, A. D., Hermans, P., Goebel, F., Blaxhult, A., Kirk, O., Phillips, A. N., et al. (2002) · The Journal of Infectious Diseases · doi:10.1086/338267 · Cited by 129
Press, N., TYNDALL, M. W., Wood, E., Hogg, R. S., & Montaner, J. S. G. (2002) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200212153-00005 · Cited by 116
Research works printed but not linked: 1
- Christensen PB, 1998, Ugeskr Laeger, 160, 3529
Cited by
Sorted by citations
Items 701–748 of 748
Antiretroviral Treatment (ART) of Adult HIV Infection
Aberg, J. A., Cahn, P. E., & Montaner, J. S. G. (2010)
HIV infection and hypertension: Epidemiological and pathogenetic aspects
Manner, I. W. (2013) · NORA - Norwegian Open Research Archives
Williams, K. M., & Johnson, A. S. (2015) · American Public Health Association eBooks · doi:10.2105/9780875532752ch01
11 Fertility treatments in human immunodeficiency virus (HIV) infected patients
Olshtain‐Pops, K., & Maayan, S. L. (2011) · De Gruyter eBooks · doi:10.1515/9783110240214.131
Motshwane, M. M., & Seeletse, S. M. (2016) · American Journal of Applied Sciences · doi:10.3844/ajassp.2016.924.931
Towards a Cure: HIV Reservoirs and Strategies to control them
Schrijvers, R., Rijck, J. D., Gijsbers, R., Ronen, K., Bushman, K., & Debyser, Z. (2010)
Payne, G. A., & Overton, E. T. (2016) · Journal of Nuclear Cardiology · doi:10.1007/s12350-016-0731-9
C URRENT OPINION Is the central nervous system a reservoir of HIV-1?
Gray, L. R., Roche, M., Flynn, J. K., Wesselingh, S. L., Gorry, P. R., & Churchill, M. J. (2014)
Drozd, D. R. (2015) · ResearchWorks at the University of Washington (University of Washington)
ЭКСПАНСИЯ Т-ЛИМФОЦИТОВ CD8+ ПРИ КОИНФЕКЦИИ ВИЧ/ВГС СВЯЗАНА С СИСТЕМНЫМ ВОСПАЛЕНИЕМ
Сайдакова, Е. В., Владимирович, Ш. К., Королевская, Л. Б., Геннадьевна, Ш. Н., & Черешнев, В. А. (2017) · Доклады Академии наук · doi:10.7868/s0869565217130266
Transition from diagnosis to regular medication use for adults with HIV/AIDS infection
Wang, S., Liu, S., & Huang, Y. (2017) · Journal of Nursing Education and Practice · doi:10.5430/jnep.v7n12p123
Hinoshita, F., Katsuki, T., Teruya, K., Shioji, S., Beppu, H., Sakamoto, E., Akagi, Y., Mitani, Y., & Tada, M. (2018) · Nihon Toseki Igakkai Zasshi · doi:10.4009/jsdt.51.313
Human Immunodeficiency Virus and Bone
Yin, M. T., & Brown, T. T. (2018) · Wiley eBooks · doi:10.1002/9781119266594.ch60
Imamura, A. (2017) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.106.2320
Mimiesse, F. J., Ahoui-Apendi, C., Itoua-Ngaporo, N. A., Koukha, U. I., Ollandzobo, L. C. A., Mongo‐Onkouo, A., Ngalessami-Mouakosso, M., Adoua, C. S., Mokoko, J. B., Ngami, R. S., et al. (2019) · Open Journal of Gastroenterology · doi:10.4236/ojgas.2019.98016
Cocaine Use: A Threat for the HIV-Infected Liver
Fuster, D. (2020) · Journal of Women s Health · doi:10.1089/jwh.2019.8284
Mina, Y., Smith, B., & Nath, A. (2020) · Encyclopedia of Life Sciences · doi:10.1002/9780470015902.a0000006.pub2
Principles of management of HIV in the developed world
Hull, M., Harris, M., & Montaner, J. S. G. (2010) · Elsevier eBooks · doi:10.1016/b978-0-323-04579-7.00099-x
HIV/AIDS and Opportunistic Illnesses
Hoffmann, C. J., & Chaisson, R. E. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-4470-3.50024-0
Human immunodeficiency virus and osteoporosis
Brown, T. T., & Yin, M. T. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-813073-5.00049-6
Enhancing T-cell responses to vaccination of HIV-1 infected subjects on antiretroviral therapy
Ramirez, L. (2014) · ScholarlyCommons (University of Pennsylvania)
Préoccupations cardiovasculaires
Leclercq, P. (2009) · Médecine et Maladies Infectieuses · doi:10.1016/s0399-077x(09)73378-5
Overview of HIV-Associated Multimorbidities
Pereira, L. F., Bradley, M., Goforth, H. W., Alfonso, C. A., Lux, J. Z., Martínez, E., & Mullen, M. P. (2017) · Oxford University Press eBooks · doi:10.1093/med/9780199392742.003.0047
Portsmouth, S. (2014) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.718249547.793491422
Rivero, A., Pérez-Molina, J. A., Blasco, A. J., Arribas, J. R., Casal, M. C., Domingo, P., Estrada, V., Iribarren, J. A., Knobel, H., Lázaro, P., et al. (2017) · Enfermedades infecciosas y microbiologia clinica (English ed ) · doi:10.1016/j.eimce.2017.01.030
Pahuja, M., Merlin, J. S., & Selwyn, P. A. (2015) · doi:10.1093/med/9780199656097.003.0151
Antibiotika und Chemotherapeutika
Kern, W. V. (2015) · Springer eBooks · doi:10.1007/978-3-662-47186-9_8
Antibiotika und Chemotherapeutika
Kern, W. V. (2013) · Springer eBooks · doi:10.1007/978-3-642-37124-0_9
Antibiotika und Chemotherapeutika
Kern, W. V. (2014) · Springer eBooks · doi:10.1007/978-3-662-43487-1_9
Impact of Viral Infection by HIV-1 in Oocyte and Embryo Quality and Pregnancy Rate
Okada, L., Lazzari, V. M., Azambuja, R., Michelon, J., Badalotti, M., & Petracco, Á. (2011) · JBRA · doi:10.5935/1518-0557.2011.15.4.04
Cuidados paliativos em pacientes com HIV/Aids internados em um Hospital Universitário
Bezerra, M. (2023) · Perspectivas Experimentais e Clínicas Inovações Biomédicas e Educação em Saúde (PECIBES) · doi:10.55028/pecibes.v9i1.18180
Simapuka, B. G. L. F. (2024) · Texila international journal of academic research · doi:10.21522/tijar.2014.11.01.art001
Organizing pneumonia and usual interstitial pneumonia in a patient with HIV infection: A case report
GEORGAKOPOULOU, V. E., Kallianos, A., & Trakada, G. (2024) · Pneumon · doi:10.18332/pne/185611
Hiremath, R. N., Bhalla, S., Ghodke, S., Rai, S., Raj, R., & Singh, S. (2022) · Indian Journal of Allergy Asthma and Immunology · doi:10.4103/ijaai.ijaai_2_22
Current Status and Future Perspective of HIV-1 Infections in Japan
Takaori‐Kondo, A. (2023) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.112.1966
Factors influencing the course of infection
Pokrovskaya, A. V. (2010) · Epidemiology and Infectious Diseases · doi:10.17816/eid40512
Human Immunodeficiency Virus Types 1 and 2: Virology, Host Response, Treatment, and Prevention
Tang, J. ‘., Goepfert, P., & Kaslow, R. A. (2025) · Springer eBooks · doi:10.1007/978-1-4939-9544-8_66-1
Satisfaction With Service Delivery Among People With HIV in Taiwan: A Cross-Sectional Study
Peng, A.-T., Wu, P.-Y., Chen, L.-Y., Chang, H., Luo, Y., Chen, Y., Liu, W., Chen, Y.-C., Li, M.-L., wang, P., et al. (2025) · Journal of the International Association of Providers of AIDS Care (JIAPAC) · doi:10.1177/23259582251403910
HIV自己イメージ尺度(HIVSIS)の信頼性と妥当性の検討一予防的介入プログラムの開発に役立つ尺度の作成一
飯田, 敏., いとう, た., & 井上, 孝. (2012) · コミュニティ心理学研究 · doi:10.32236/jscpjournal.16.1_39
A literature review on local production of medicines and access to health-care
Consoli, D. (2010) · Research Explorer (The University of Manchester)
Meintjes, G. (2011) · Open University of Cape Town (University of Cape Town)
Ohmoto‐Sekine, Y., Ishihara, M., Amakawa, K., Dong, H. S., HASHIMOTO, M., Okuda, C., Kato, H., Ogawa, K., Tanabe, M., Hara, S., et al. (2012) · Ningen dock : official journal of the Japanese Society of Human Dry Dock · doi:10.11320/ningendock.26.959
Low serum testosterone concentrations predict incident frailty in men with HIV
Dias, J. P., Fitzgerald, K. C., Seaberg, E., Wolinsky, S., Lake, J. E., Koletar, S. L., Shardell, M. D., Basaria, S. S., & Brown, T. T. (2026) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgag252
Hunt, P. W., Sezgin, E., Olshen, A. B., Murad, N., Ambayec, G. C., Schneider, M. F., & Jabs, D. A. (2026) · Ophthalmology Science · doi:10.1016/j.xops.2026.101318
Cellular and biochemical effects induced by antiretroviral drugs.
Anwar, K. (2013) · ResearchSpace (University of KwaZulu-Natal)
Metadata
- Authors
- Lohse, N., Hansen, A.-B. E., Pedersen, G., Kronborg, G., Gerstoft, J., Sørensen, H. T., Væth, M., & Obel, N.
- Affiliations
- Boston University (US)
- ORCID
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2007-01-16
- Volume
- 146
- Issue
- 2
- Pages
- 87-95
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W1967548282
- Cited by
- 748
- References
- 21
- Citations by year
- 2026: 3 · 2025: 8 · 2024: 15 · 2023: 9 · 2022: 14 · 2021: 17 · 2020: 19 · 2019: 15 · 2018: 34 · 2017: 32 · 2016: 44 · 2015: 54 · 2014: 62 · 2013: 75 · 2012: 73
- FWCI
- 39.70
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annals of Internal Medicine (publishedVersion)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- University of Southern Denmark Research Portal (University of Southern Denmark) (submittedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
- Health Sciences › Medicine › Infectious Diseases › HIV-related health complications and treatments
- Health Sciences › Medicine › Epidemiology › HIV, Drug Use, Sexual Risk
- Keywords
- HIV infection, survival, mortality, age-specific mortality, excess mortality, hepatitis C coinfection, highly active antiretroviral therapy, HIV cohort, Denmark, life tables, HIV treatment outcomes
- MeSH terms
- Adult, Cause of Death, Denmark, Female, Hepatitis C, Humans, Life Expectancy, Male, Middle Aged, Prospective Studies, HIV Infections, Survival Rate, Case-Control Studies, Antiretroviral Therapy, Highly Active
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review